Carbon monoxide-releasing molecule CORM-3 suppresses vascular endothelial cell SOD-1/SOD-2 activity while up-regulating the cell surface levels of SOD-3 in a heparin-dependent manner

Free Radical Biology and Medicine

Volumn 49, Issue 10, 2010, Pages 1534-1541

  Mizuguchi, Shinjiro ^a   Capretta, Alfredo ^b   Suehiro, Shigefumi ^c   Nishiyama, Noritoshi ^c   Luke, Patrick ^d   Potter, Richard F ^a   Fraser, Douglas D ^a   Cepinskas, Gediminas ^a  

^a LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Antioxidant enzymes; Cell culture; Free radicals; Heparin; Inflammation; Oxidative stress; Vascular endothelium

Indexed keywords

ANTIOXIDANT; CARBON MONOXIDE; CARBON MONOXIDE RELEASING MOLECULE 3; CARBONYL DERIVATIVE; COPPER ZINC SUPEROXIDE DISMUTASE; EXTRACELLULAR SUPEROXIDE DISMUTASE; HEPARIN; MANGANESE SUPEROXIDE DISMUTASE; OXIDOREDUCTASE; RUTHENIUM; UNCLASSIFIED DRUG;

ARTICLE; BINDING COMPETITION; CELL CULTURE; CELL FREE SYSTEM; CELL SURFACE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME BINDING; ENZYME RELEASE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; UPREGULATION; VASCULAR ENDOTHELIUM;

CARBON MONOXIDE; CELL-FREE SYSTEM; CELLS, CULTURED; ENDOTHELIAL CELLS; HEPARIN; HUMANS; ORGANOMETALLIC COMPOUNDS; SUPEROXIDE DISMUTASE; UP-REGULATION;

EID: 77957753616     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2010.08.017     Document Type: Article

References (46)

1. Otterbein L.E., Soares M.P., Yamashita K., Bach F.H. Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol. 2003, 24:449-455.
2. Sawle P., Foresti R., Mann B.E., Johnson T.R., Green C.J., Motterlini R. Carbon monoxide-releasing molecules (CO-RMs) attenuate the inflammatory response elicited by lipopolysaccharide in RAW264.7 murine macrophages. Br. J. Pharmacol. 2005, 145:800-810.
3. Cepinskas G., Katada K., Bihari A., Potter R.F. Carbon monoxide liberated from carbon monoxide-releasing molecule CORM-2 attenuates inflammation in the liver of septic mice. Am. J. Physiol. 2008, 294:G184-G191.
4. Chung S.W., Liu X., Macias A.A., Baron R.M., Perrella M.A. Heme oxygenase-1-derived carbon monoxide enhances the host defense response to microbial sepsis in mice. J. Clin. Invest. 2008, 118:239-247.
5. Guo Y., Stein A.B., Wu W.J., Tan W., Zhu X., Li Q.H., Dawn B., Motterlini R., Bolli R. Administration of a CO-releasing molecule at the time of reperfusion reduces infarct size in vivo. Am. J. Physiol. Heart Circ. Physiol. 2004, 286:H1649-H1653.
6. Katada K., Bihari A., Mizuguchi S., Yoshida N., Yoshikawa T., Fraser D.D., Potter R.F., Cepinskas G. Carbon monoxide liberated from CO-releasing molecule (CORM-2) attenuates ischemia/reperfusion (I/R)-induced inflammation in the small intestine. Inflammation 2010, 33:92-100.
7. Motterlini R. Carbon monoxide-releasing molecules (CO-RMs): vasodilatory, anti-ischaemic and anti-inflammatory activities. Biochem. Soc. Trans. 2007, 35:1142-1146.
8. Song R., Kubo M., Morse D., Zhou Z., Zhang X., Dauber J.H., Fabisiak J., Alber S.M., Watkins S.C., Zuckerbraun B.S., Otterbein L.E., Ning W., Oury T.D., Lee P.J., McCurry K.R., Choi A.M. Carbon monoxide induces cytoprotection in rat orthotopic lung transplantation via anti-inflammatory and anti-apoptotic effects. Am. J. Pathol. 2003, 163:231-242.
9. Zuckerbraun B.S., Chin B.Y., Wegiel B., Billiar T.R., Czsimadia E., Rao J., Shimoda L., Ifedigbo E., Kanno S., Otterbein L.E. Carbon monoxide reverses established pulmonary hypertension. J. Exp. Med. 2006, 203:2109-2119.
10. Zuckerbraun B.S., McCloskey C.A., Gallo D., Liu F., Ifedigbo E., Otterbein L.E., Billiar T.R. Carbon monoxide prevents multiple organ injury in a model of hemorrhagic shock and resuscitation. Shock (Augusta) 2005, 23:527-532.
11. De Backer O., Elinck E., Blanckaert B., Leybaert L., Motterlini R., Lefebvre R.A. Water-soluble CO-releasing molecules reduce the development of postoperative ileus via modulation of MAPK/HO-1 signalling and reduction of oxidative stress. Gut 2009, 58:347-356.
12. Ryter S.W., Otterbein L.E. Carbon monoxide in biology and medicine. Bioessays 2004, 26:270-280.
13. Motterlini R., Clark J.E., Foresti R., Sarathchandra P., Mann B.E., Green C.J. Carbon monoxide-releasing molecules: characterization of biochemical and vascular activities. Circ. Res. 2002, 90:E17-E24.
14. Motterlini R., Sawle P., Hammad J., Bains S., Alberto R., Foresti R., Green C.J. CORM-A1: a new pharmacologically active carbon monoxide-releasing molecule. FASEB J. 2005, 19:284-286.
15. Bilban M., Haschemi A., Wegiel B., Chin B.Y., Wagner O., Otterbein L.E. Heme oxygenase and carbon monoxide initiate homeostatic signaling. J. Mol. Med. (Berlin) 2008, 86:267-279.
16. Boczkowski J., Poderoso J.J., Motterlini R. CO-metal interaction: vital signaling from a lethal gas. Trends Biochem. Sci. 2006, 31:614-621.
17. Otterbein L.E. The evolution of carbon monoxide into medicine. Respir. Care 2009, 54:925-932.
18. Faraci F.M., Didion S.P. Vascular protection: superoxide dismutase isoforms in the vessel wall. Arterioscler. Thromb. Vasc. Biol. 2004, 24:1367-1373.
19. Zelko I.N., Mariani T.J., Folz R.J. Superoxide dismutase multigene family: a comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression. Free Radic. Biol. Med. 2002, 33:337-349.
20. Lookene A., Stenlund P., Tibell L.A. Characterization of heparin binding of human extracellular superoxide dismutase. Biochemistry 2000, 39:230-236.
21. Marklund S.L. Human copper-containing superoxide dismutase of high molecular weight. Proc. Natl Acad. Sci. USA 1982, 79:7634-7638.
22. Fukai T., Folz R.J., Landmesser U., Harrison D.G. Extracellular superoxide dismutase and cardiovascular disease. Cardiovasc. Res. 2002, 55:239-249.
23. Clark J.E., Naughton P., Shurey S., Green C.J., Johnson T.R., Mann B.E., Foresti R., Motterlini R. Cardioprotective actions by a water-soluble carbon monoxide-releasing molecule. Circ. Res. 2003, 93:e2-e8.
24. Urquhart P., Rosignoli G., Cooper D., Motterlini R., Perretti M. Carbon monoxide-releasing molecules modulate leukocyte-endothelial interactions under flow. J. Pharmacol. Exp. Ther. 2007, 321:656-662.
25. Cepinskas G., Savickiene J., Ionescu C.V., Kvietys P.R. PMN transendothelial migration decreases nuclear NFkappaB in IL-1beta-activated endothelial cells: role of PECAM-1. J. Cell Biol. 2003, 161:641-651.
26. Mizuguchi S., Stephen J., Dencev-Bihari R., Markovic N., Suehiro S., Capretta F., Potter R.F., Cepinskas G. CORM-3-derived CO modulates polymorphonuclear leukocyte migration across the vascular endothelium by reducing levels of cell surface-bound elastase. Am. J. Physiol. Heart Circ. Physiol. 2009, 297:H920-H929.
27. Ganta V.C., Alexander J.S. Focus on carbon monoxide: a modulator of neutrophil oxidants and elastase spatial localization?. Am. J. Physiol. Heart Circ. Physiol. 2009, 297:H902-H904.
28. Taille C., El-Benna J., Lanone S., Boczkowski J., Motterlini R. Mitochondrial respiratory chain and NAD(P)H oxidase are targets for the antiproliferative effect of carbon monoxide in human airway smooth muscle. J. Biol. Chem. 2005, 280:25350-25360.
29. Zuckerbraun B.S., Chin B.Y., Bilban M. d'Avila, J. C.; Rao, J.; Billiar, T. R.; Otterbein, L. E. Carbon monoxide signals via inhibition of cytochrome c oxidase and generation of mitochondrial reactive oxygen species. FASEB J. 2007, 21:1099-1106.
30. Foresti R., Bani-Hani M.G., Motterlini R. Use of carbon monoxide as a therapeutic agent: promises and challenges. Intens. Care Med. 2008, 34:649-658.
31. Otterbein L.E., Bach F.H., Alam J., Soares M., Tao Lu H., Wysk M., Davis R.J., Flavell R.A., Choi A.M. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat. Med. 2000, 6:422-428.
32. Piantadosi C.A. Carbon monoxide, reactive oxygen signaling, and oxidative stress. Free Radic. Biol. Med. 2008, 45:562-569.
33. Hoetzel A., Dolinay T., Schmidt R., Choi A.M., Ryter S.W. Carbon monoxide in sepsis. Antioxid. Redox Signaling 2007, 9:2013-2026.
34. Desmard M., Amara N., Lanone S., Motterlini R., Boczkowski J. Carbon monoxide reduces the expression and activity of matrix metalloproteinases 1 and 2 in alveolar epithelial cells. Cell. Mol. Biol. (Noisy-le-Grand) 2005, 51:403-408.
35. Doukov T.I., Iverson T.M., Seravalli J., Ragsdale S.W., Drennan C.L. A Ni-Fe-Cu center in a bifunctional carbon monoxide dehydrogenase/acetyl-CoA synthase. Science 2002, 298:567-572.
36. Lucas H.R., Karlin K.D. Copper-carbon bonds in mechanistic and structural probing of proteins as well as in situations where copper is a catalytic or receptor site. Metal Ions Life Sci. 2009, 6:295-361.
37. Lucas H.R., Meyer G.J., Karlin K.D. Carbon monoxide and nitrogen monoxide ligand dynamics in synthetic heme and heme-copper complex systems. J. Am. Chem. Soc. 2009, 131:13924-13925.
38. Suzuki K., Tatsumi H., Satoh S., Senda T., Nakata T., Fujii J., Taniguchi N. Manganese-superoxide dismutase in endothelial cells: localization and mechanism of induction. Am. J. Physiol. 1993, 265:H1173-H1178.
39. Oury T.D., Day B.J., Crapo J.D. Extracellular superoxide dismutase: a regulator of nitric oxide bioavailability. Lab. Invest. 1996, 75:617-636.
40. Marklund S.L. Extracellular superoxide dismutase and other superoxide dismutase isoenzymes in tissues from nine mammalian species. Biochem. J. 1984, 222:649-655.
41. Qin Z., Reszka K.J., Fukai T., Weintraub N.L. Extracellular superoxide dismutase (ecSOD) in vascular biology: an update on exogenous gene transfer and endogenous regulators of ecSOD. Transl. Res. 2008, 151:68-78.
42. Sandstrom J., Carlsson L., Marklund S.L., Edlund T. The heparin-binding domain of extracellular superoxide dismutase C and formation of variants with reduced heparin affinity. J. Biol. Chem. 1992, 267:18205-18209.
43. Karlsson K., Marklund S.L. Heparin-induced release of extracellular superoxide dismutase to human blood plasma. Biochem. J. 1987, 242:55-59.
44. Campbell E.J., Owen C.A. The sulfate groups of chondroitin sulfate- and heparan sulfate-containing proteoglycans in neutrophil plasma membranes are novel binding sites for human leukocyte elastase and cathepsin G. J. Biol. Chem. 2007, 282:14645-14654.
45. Patel M.K., Refson J.S., Schachter M., Hughes A.D. Characterization of [3H]-heparin binding in human vascular smooth muscle cells and its relationship to the inhibition of DNA synthesis. Br. J. Pharmacol. 1999, 127:361-368.
46. Davydova M.N., Tarasova N.B. Carbon monoxide inhibits superoxide dismutase and stimulates reactive oxygen species production by Desulfovibrio desulfuricans 1388. Anaerobe 2005, 11:335-338.